摘要
肝源性糖尿病(HD)是终末期肝病的常见并发症,对患者预后的不良影响已得到大量研究证实。近十年国内外对HD的发病机制进行了大量研究,取得了一些进展。系统综述了HD的发病机制研究进展,为临床医生的诊断与治疗HD提供参考。
Hepatogenous diabetes(HD)is a common complication of end-stage liver disease,and many studies have confirmed its adverse effect on prognosis.In recent ten years,a great number of studies have been conducted on the pathogenesis of HD and some progress has been made.This article reviews the research advances in the pathogenesis of HD,in order to provide a reference for the diagnosis and treatment of HD by clinicians.
作者
胡晗
田彩云
张国远
林世德
HU Han;TIAN Caiyun;ZHANG Guoyuan;LIN Shide(Department of Infectious Diseases,The Affiliated Hospital of Zunyi Medical University,Zunyi,Guizhou 563003,China)
出处
《临床肝胆病杂志》
CAS
北大核心
2021年第2期429-432,共4页
Journal of Clinical Hepatology
基金
国家自然科学基金(81860114/H0316)。
关键词
肝硬化
肝源性糖尿病
胰岛素抗药性
Liver Cirrhosis
Hepatogenous Diabetes
Insulin Resistance
